Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Clinical trial NCT03742687 · RECRUITING

Trial details

NCT number: NCT03742687
Sponsor: Danish Lung Cancer Group
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage III Non-small-cell Lung Cancer Stage IV Non-small Cell Lung Cancer Radiotherapy Side Effect

Start date: 2018-11-22
Primary completion: 2023-12-30
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.